Sodium in PDB 4d7c: Monoclinic Crystal Form of the Extracellular Olfactomedin Domain From Gliomedin
Protein crystallography data
The structure of Monoclinic Crystal Form of the Extracellular Olfactomedin Domain From Gliomedin, PDB code: 4d7c
was solved by
H.Han,
P.Kursula,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.084 /
1.45
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
37.550,
141.700,
46.030,
90.00,
110.61,
90.00
|
R / Rfree (%)
|
17.34 /
21.24
|
Sodium Binding Sites:
The binding sites of Sodium atom in the Monoclinic Crystal Form of the Extracellular Olfactomedin Domain From Gliomedin
(pdb code 4d7c). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 2 binding sites of Sodium where determined in the
Monoclinic Crystal Form of the Extracellular Olfactomedin Domain From Gliomedin, PDB code: 4d7c:
Jump to Sodium binding site number:
1;
2;
Sodium binding site 1 out
of 2 in 4d7c
Go back to
Sodium Binding Sites List in 4d7c
Sodium binding site 1 out
of 2 in the Monoclinic Crystal Form of the Extracellular Olfactomedin Domain From Gliomedin
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Monoclinic Crystal Form of the Extracellular Olfactomedin Domain From Gliomedin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na1544
b:11.1
occ:1.00
|
O
|
A:ALA472
|
2.3
|
10.3
|
1.0
|
O
|
A:LEU517
|
2.3
|
10.0
|
1.0
|
OD1
|
A:ASN423
|
2.3
|
13.0
|
1.0
|
OD1
|
A:ASN471
|
2.4
|
10.9
|
1.0
|
O
|
A:HOH2188
|
2.5
|
12.4
|
1.0
|
O
|
A:HOH2189
|
2.9
|
17.8
|
1.0
|
H
|
A:ALA472
|
3.0
|
11.8
|
1.0
|
HB3
|
A:LEU517
|
3.1
|
12.4
|
1.0
|
H
|
A:LEU517
|
3.2
|
11.6
|
1.0
|
CG
|
A:ASN423
|
3.4
|
13.6
|
1.0
|
C
|
A:LEU517
|
3.4
|
10.6
|
1.0
|
C
|
A:ALA472
|
3.5
|
10.2
|
1.0
|
HD22
|
A:ASN423
|
3.5
|
17.7
|
1.0
|
CG
|
A:ASN471
|
3.6
|
9.5
|
1.0
|
N
|
A:ALA472
|
3.8
|
9.8
|
1.0
|
N
|
A:LEU517
|
3.9
|
9.6
|
1.0
|
ND2
|
A:ASN423
|
3.9
|
14.7
|
1.0
|
CB
|
A:LEU517
|
3.9
|
10.3
|
1.0
|
HE2
|
A:PHE415
|
3.9
|
12.7
|
1.0
|
CA
|
A:LEU517
|
3.9
|
9.7
|
1.0
|
HD22
|
A:ASN471
|
4.0
|
14.7
|
1.0
|
HG
|
A:SER518
|
4.2
|
21.0
|
0.2
|
HA
|
A:PHE473
|
4.2
|
11.8
|
1.0
|
CA
|
A:ALA472
|
4.2
|
10.6
|
1.0
|
ND2
|
A:ASN471
|
4.3
|
12.2
|
1.0
|
O
|
A:HOH2103
|
4.4
|
18.9
|
1.0
|
HB3
|
A:PHE473
|
4.4
|
12.4
|
1.0
|
HA
|
A:SER518
|
4.4
|
16.4
|
0.2
|
HA
|
A:SER518
|
4.4
|
15.5
|
0.8
|
HB2
|
A:LEU517
|
4.5
|
12.4
|
1.0
|
CE2
|
A:PHE415
|
4.5
|
10.6
|
1.0
|
N
|
A:PHE473
|
4.5
|
10.7
|
1.0
|
O
|
A:HOH2180
|
4.6
|
15.4
|
1.0
|
N
|
A:SER518
|
4.6
|
11.6
|
0.2
|
N
|
A:SER518
|
4.6
|
11.0
|
0.8
|
HB1
|
A:ALA472
|
4.6
|
13.5
|
1.0
|
HG
|
A:LEU517
|
4.6
|
12.9
|
1.0
|
HD21
|
A:LEU517
|
4.6
|
14.4
|
1.0
|
CB
|
A:ASN423
|
4.7
|
12.4
|
1.0
|
HB3
|
A:ASN471
|
4.7
|
12.4
|
1.0
|
CB
|
A:ASN471
|
4.7
|
10.3
|
1.0
|
OG
|
A:SER518
|
4.7
|
17.5
|
0.2
|
HB2
|
A:ASN423
|
4.7
|
14.9
|
1.0
|
HD21
|
A:ASN423
|
4.7
|
17.7
|
1.0
|
CA
|
A:PHE473
|
4.8
|
9.8
|
1.0
|
CG
|
A:LEU517
|
4.8
|
10.8
|
1.0
|
HA
|
A:LEU517
|
4.9
|
11.6
|
1.0
|
HA
|
A:MET516
|
4.9
|
12.4
|
1.0
|
HD2
|
A:PHE415
|
4.9
|
13.4
|
1.0
|
HB2
|
A:SER518
|
4.9
|
17.6
|
0.8
|
C
|
A:ASN471
|
4.9
|
9.5
|
1.0
|
CA
|
A:SER518
|
5.0
|
13.6
|
0.2
|
CA
|
A:SER518
|
5.0
|
12.9
|
0.8
|
HD13
|
A:ILE434
|
5.0
|
15.8
|
1.0
|
HA
|
A:ASN471
|
5.0
|
11.7
|
1.0
|
HB3
|
A:ASN423
|
5.0
|
14.9
|
1.0
|
|
Sodium binding site 2 out
of 2 in 4d7c
Go back to
Sodium Binding Sites List in 4d7c
Sodium binding site 2 out
of 2 in the Monoclinic Crystal Form of the Extracellular Olfactomedin Domain From Gliomedin
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Monoclinic Crystal Form of the Extracellular Olfactomedin Domain From Gliomedin within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na1544
b:13.5
occ:1.00
|
HD22
|
B:ASN423
|
1.6
|
16.9
|
0.2
|
OD1
|
B:ASN423
|
1.9
|
10.4
|
0.8
|
ND2
|
B:ASN423
|
2.1
|
14.1
|
0.2
|
OD1
|
B:ASN423
|
2.3
|
12.6
|
0.2
|
O
|
B:ALA472
|
2.3
|
11.1
|
1.0
|
CG
|
B:ASN423
|
2.4
|
13.2
|
0.2
|
O
|
B:LEU517
|
2.4
|
12.6
|
1.0
|
O
|
B:HOH2152
|
2.5
|
13.0
|
1.0
|
OD1
|
B:ASN471
|
2.6
|
10.5
|
1.0
|
HD21
|
B:ASN423
|
2.8
|
16.9
|
0.2
|
O
|
B:HOH2151
|
2.8
|
15.6
|
1.0
|
HD22
|
B:ASN423
|
2.9
|
17.6
|
0.8
|
CG
|
B:ASN423
|
2.9
|
13.1
|
0.8
|
H
|
B:ALA472
|
3.2
|
12.3
|
1.0
|
ND2
|
B:ASN423
|
3.2
|
14.6
|
0.8
|
HB3
|
B:LEU517
|
3.4
|
11.9
|
1.0
|
H
|
B:LEU517
|
3.4
|
11.9
|
1.0
|
C
|
B:ALA472
|
3.5
|
11.0
|
1.0
|
C
|
B:LEU517
|
3.5
|
11.0
|
1.0
|
HE2
|
B:PHE415
|
3.8
|
14.8
|
1.0
|
CG
|
B:ASN471
|
3.8
|
10.0
|
1.0
|
CB
|
B:ASN423
|
3.9
|
12.3
|
0.2
|
N
|
B:ALA472
|
4.0
|
10.2
|
1.0
|
HA
|
B:PHE473
|
4.1
|
12.7
|
1.0
|
N
|
B:LEU517
|
4.1
|
9.9
|
1.0
|
HB2
|
B:ASN423
|
4.1
|
14.7
|
0.2
|
HD21
|
B:ASN423
|
4.1
|
17.6
|
0.8
|
CA
|
B:LEU517
|
4.2
|
9.9
|
1.0
|
CB
|
B:LEU517
|
4.2
|
9.9
|
1.0
|
CB
|
B:ASN423
|
4.2
|
12.5
|
0.8
|
HD22
|
B:ASN471
|
4.3
|
16.6
|
1.0
|
HA
|
B:SER518
|
4.3
|
13.4
|
0.7
|
HA
|
B:SER518
|
4.3
|
14.5
|
0.3
|
HB3
|
B:ASN423
|
4.3
|
14.7
|
0.2
|
CA
|
B:ALA472
|
4.3
|
10.3
|
1.0
|
HB3
|
B:PHE473
|
4.4
|
12.8
|
1.0
|
HB2
|
B:ASN423
|
4.4
|
15.0
|
0.8
|
CE2
|
B:PHE415
|
4.5
|
12.3
|
1.0
|
ND2
|
B:ASN471
|
4.5
|
13.8
|
1.0
|
HB1
|
B:ALA472
|
4.5
|
12.9
|
1.0
|
N
|
B:PHE473
|
4.5
|
11.4
|
1.0
|
HB3
|
B:ASN423
|
4.6
|
15.0
|
0.8
|
N
|
B:SER518
|
4.6
|
10.6
|
1.0
|
CA
|
B:PHE473
|
4.7
|
10.6
|
1.0
|
O
|
B:HOH2085
|
4.7
|
20.2
|
1.0
|
HG
|
B:LEU517
|
4.7
|
13.3
|
1.0
|
HB2
|
B:SER518
|
4.7
|
13.8
|
0.7
|
OG
|
B:SER518
|
4.8
|
14.3
|
0.3
|
HD21
|
B:LEU517
|
4.8
|
14.8
|
1.0
|
HB2
|
B:LEU517
|
4.8
|
11.9
|
1.0
|
HD13
|
B:ILE434
|
4.8
|
17.8
|
1.0
|
O
|
B:HOH2148
|
4.9
|
15.8
|
1.0
|
CA
|
B:SER518
|
4.9
|
11.2
|
0.7
|
CA
|
B:SER518
|
4.9
|
12.1
|
0.3
|
HB3
|
B:ASN471
|
4.9
|
13.8
|
1.0
|
CB
|
B:ASN471
|
5.0
|
11.5
|
1.0
|
HA2
|
B:GLY370
|
5.0
|
13.3
|
1.0
|
HD2
|
B:PHE415
|
5.0
|
14.8
|
1.0
|
|
Reference:
H.Han,
P.Kursula.
The Olfactomedin Domain From Gliomedin Is A Beta-Propeller with Unique Structural Properties J.Biol.Chem. 2014.
ISSN: ESSN 1083-351X
DOI: 10.1074/JBC.M114.627547
Page generated: Mon Oct 7 14:51:20 2024
|